Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alén, M(arkku) |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Jartti, T(uomas) |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A(ndré) H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y(rjö) A(ntero) |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P(etri) |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J(ohanna) |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S(imo) |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T(aina) |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis. | Kesäniemi, Y(rjö) A(ntero) | 344 days | save |  |  | |
| Peptide Hormones and Risk for Future Cardiovascular Events among Prediabetics: A 20-Year Follow-Up in the Opera Study. | Kesäniemi, Y(rjö) A(ntero) | 582 days | save | | | |
| Metabolic syndrome but not genetic polymorphisms known to induce NAFLD predicts increased total mortality in subjects with NAFLD (OPERA study). | Kesäniemi, Y(rjö) A(ntero) | 666 days | save | | | |
| The validity of hospital discharge register data on non-ST-elevation and ST-elevation myocardial infarction in Finland. | Kesäniemi, Y(rjö) A(ntero) | 706 days | save | | | |
| Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis. | Kesäniemi, Y(rjö) A(ntero) | 739 days | save | | | |
| Non-dipping blood pressure pattern and new-onset diabetes in a 21-year follow-up. | Kesäniemi, Y(rjö) A(ntero) | 882 days | save | | | |
| Life style habits, biochemical factors and their interaction in the prediction of incident hypertension during 21-year follow-up. | Kesäniemi, Y(rjö) A(ntero) | 1052 days | save | | | |
| Title: Dietary Sodium Intake is Associated with Long-Term Risk of New-Onset Atrial Fibrillation. | Kesäniemi, Y(rjö) A(ntero) | 1062 days | save | | | |
| Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study). | Kesäniemi, Y(rjö) A(ntero) | 1105 days | save | | | |
| Effect of simvastatin and ezetimibe on suPAR levels and outcomes. | Kesäniemi, Y(rjö) A(ntero) | 1294 days | save | | | |
| Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study. | Kesäniemi, Y(rjö) A(ntero) | 1322 days | save | | | |
| Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up. | Kesäniemi, Y(rjö) A(ntero) | 1344 days | save | | | |
| Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study). | Kesäniemi, Y(rjö) A(ntero) | 1360 days | save | | | |
| IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk. | Kesäniemi, Y(rjö) A(ntero) | 1388 days | save | | | |
| Case fatality of acute coronary events is improving even among elderly patients; the FINAMI study 1995-2012. | Kesäniemi, Y(rjö) A(ntero) | 1485 days | save | | | |
| Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up. | Kesäniemi, Y(rjö) A(ntero) | 1490 days | save | | | |
| Cardiac Remodeling from Middle Age to Senescence. | Kesäniemi, Y(rjö) A(ntero) | 1585 days | save | | | |
| A Low-Frequency Inactivating Akt2 Variant Enriched in the Finnish Population is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. | Kesäniemi, Y(rjö) A(ntero) | 1662 days | save | | | |
| Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population. | Kesäniemi, Y(rjö) A(ntero) | 1676 days | save | | | |
| Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. | Kesäniemi, Y(rjö) A(ntero) | 1691 days | save | | | |
| Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use. | Kesäniemi, Y(rjö) A(ntero) | 1800 days | save | | | |
| SuPAR Predicts Cardiovascular Events and Mortality in Patients With Asymptomatic Aortic Stenosis. | Kesäniemi, Y(rjö) A(ntero) | 1893 days | save | | | |
| Assessing Optimal Blood Pressure in Patients with Asymptomatic Aortic Valve Stenosis: The SEAS Study. | Kesäniemi, Y(rjö) A(ntero) | 1897 days | save | | | |
| Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes. | Kesäniemi, Y(rjö) A(ntero) | 1914 days | save | | | |
| Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). | Kesäniemi, Y(rjö) A(ntero) | 2159 days | save | | | |
| Predictors of Development of Echocardiographic Left Ventricular Diastolic Dysfunction in the Subjects Aged 40 to 59 Years (from the Oulu Project Elucidating Risk of Atherosclerosis Study). | Kesäniemi, Y(rjö) A(ntero) | 2231 days | save | | | |
| Dietary sodium intake and prediction of cardiovascular events. | Kesäniemi, Y(rjö) A(ntero) | 2395 days | save | | | |
| High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy. | Kesäniemi, Y(rjö) A(ntero) | 2432 days | save | | | |
| Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial. | Kesäniemi, Y(rjö) A(ntero) | 2571 days | save | | | |
| High plasma ghrelin protects from coronary heart disease and Leu72Leu polymorphism of ghrelin gene from cancer in healthy adults during the 19 years follow-up study. | Kesäniemi, Y(rjö) A(ntero) | 2575 days | save | | | |
| Prognostic Significance of Impaired Baroreflex Sensitivity Assessed from Phase IV of the Valsalva Maneuver in a Population-Based Sample of Middle-Aged Subjects. | Kesäniemi, Y(rjö) A(ntero) | 2651 days | save | | | |
| Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. | Kesäniemi, Y(rjö) A(ntero) | 2764 days | save | | | |
| Heart Rate Variability Findings as a Predictor of Atrial Fibrillation in Middle-Aged Population. | Kesäniemi, Y(rjö) A(ntero) | 2776 days | save | | | |
| Circulating cell-free DNA is associated with cardiometabolic risk factors: The Health 2000 Survey. | Kesäniemi, Y(rjö) A(ntero) | 2796 days | save | | | |
| An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report. | Kesäniemi, Y(rjö) A(ntero) | 2796 days | save | | | |
| An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia: Executive summary. | Kesäniemi, Y(rjö) A(ntero) | 2816 days | save | | | |
| An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia. | Kesäniemi, Y(rjö) A(ntero) | 2821 days | save | | | |
| Leptin Receptor Arg109 Homozygotes Display Decreased Total Mortality as well as Lower Incidence of Cardiovascular Disease and Related Death. | Kesäniemi, Y(rjö) A(ntero) | 2915 days | save | | | |
| Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes. | Kesäniemi, Y(rjö) A(ntero) | 2919 days | save | | | |
| Long-term fructose feeding changes the expression of leptin receptors and autophagy genes in the adipose tissue and liver of male rats: a possible link to elevated triglycerides. | Kesäniemi, Y(rjö) A(ntero) | 2934 days | save | | | |
| Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. | Kesäniemi, Y(rjö) A(ntero) | 2936 days | save | | | |
| Metabolic syndrome in the prediction of cardiovascular events: The potential additive role of hsCRP and adiponectin. | Kesäniemi, Y(rjö) A(ntero) | 3037 days | save | | | |
| Peptide hormones in infants with feeding disorders. | Kesäniemi, Y(rjö) A(ntero) | 3075 days | save | | | |
| Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future. | Kesäniemi, Y(rjö) A(ntero) | 3100 days | save | | | |
| A Blood Pressure Genetic Risk Score Is a Significant Predictor of Incident Cardiovascular Events in 32 669 Individuals. | Kesäniemi, Y(rjö) A(ntero) | 3131 days | save | | | |
| Target organ damage and masked hypertension in the general population: the Finn-Home study. | Kesäniemi, Y(rjö) A(ntero) | 3143 days | save | | | |
| Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR<sup>-/-</sup> mice and bind plasma autoantibodies in humans under enhanced carbamylation. | Kesäniemi, Y(rjö) A(ntero) | 3195 days | save | | | |
| Long telomeres in blood leukocytes are associated with a high risk of ascending aortic aneurysm. | Kesäniemi, Y(rjö) A(ntero) | 3236 days | save | | | |
| Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk. | Kesäniemi, Y(rjö) A(ntero) | 3251 days | save | | | |
| Fish consumption, omega-3 fatty acids, and environmental contaminants in relation to low-grade inflammation and early atherosclerosis. | Kesäniemi, Y(rjö) A(ntero) | 3278 days | save | | | |
| | 
report | next » | | |
|
